1 January–31 December
Attributable to shareholders of PolyPeptide Group AG:
|
|
|
|
|
|
|
|
|
|
kEUR |
Share capital |
Share premium |
Translation reserve |
Treasury shares |
Other capital reserves |
Retained earnings |
Total |
|
|
|
|
|
|
|
|
|
|
Balance as at 1 January 2024 |
302 |
203,129 |
21,832 |
-10,394 |
1,217 |
165,139 |
381,225 |
|
|
|
|
|
|
|
|
|
|
Result for the year |
|
|
|
|
|
-19,564 |
-19,564 |
|
Remeasurement gain / (loss) on defined benefit plans, net of tax |
|
|
|
|
|
-5,098 |
-5,098 |
|
Currency exchange differences |
|
|
-523 |
|
|
|
-523 |
|
Total comprehensive income |
– |
– |
-523 |
– |
– |
-24,662 |
-25,185 |
|
|
|
|
|
|
|
|
|
|
Share-based payment |
|
|
|
|
1,204 |
|
1,204 |
|
Transfer of own shares |
|
|
|
1,996 |
-1,996 |
|
– |
|
Total transactions with owners |
– |
– |
– |
1,996 |
-792 |
– |
1,204 |
|
Balance as at 31 December 2024 |
302 |
203,129 |
21,309 |
-8,398 |
425 |
140,477 |
357,244 |
1 January–31 December
Attributable to shareholders of PolyPeptide Group AG:
|
|
|
|
|
|
|
|
|
|
kEUR |
Share capital |
Share premium |
Translation reserve |
Treasury shares |
Other capital reserves |
Retained earnings |
Total |
|
|
|
|
|
|
|
|
|
|
Balance as at 1 January 2023 |
302 |
203,129 |
14,119 |
-13,609 |
3,590 |
214,146 |
421,677 |
|
|
|
|
|
|
|
|
|
|
Result for the year |
|
|
|
|
|
-51,440 |
-51,440 |
|
Remeasurement gain / (loss) on defined benefit plans, net of tax |
|
|
|
|
|
2,433 |
2,433 |
|
Currency exchange differences |
|
|
7,713 |
|
|
|
7,713 |
|
Total comprehensive income |
– |
– |
7,713 |
– |
– |
-49,007 |
-41,294 |
|
|
|
|
|
|
|
|
|
|
Share-based payment |
|
|
|
|
842 |
|
842 |
|
Transfer of own shares |
|
|
|
3,215 |
-3,215 |
|
– |
|
Total transactions with owners |
– |
0 |
– |
3,215 |
-2,373 |
– |
842 |
|
Balance as at 31 December 2023 |
302 |
203,129 |
21,832 |
-10,394 |
1,217 |
165,139 |
381,225 |